Biliary Gene Therapy

Invention Novelty

Value Proposition

Technology Description

UCSF researchers have developed a first-in-class gene therapy using capsids for biliary
diseases. The novel biliary gene therapy from this invention may be an effective approach to
treat cholaniocyte-linked diseases and may provide an alternative to liver transplantation.

Application

Looking for Partners

Stage of Development

Related Materials

Data Availability